Literature DB >> 2328328

Season of tumour detection influences factors predicting survival of patients with breast cancer.

B H Mason1, I M Holdaway, A W Stewart, L M Neave, R G Kay.   

Abstract

The rate of initial detection of breast tumours varies during the year in a seasonal fashion, more tumours being discovered in late spring/early summer than at other times of the year. This phenomenon is particularly pronounced in young women (less than 50 years) with progesterone receptor positive tumours. The present study investigates whether season of tumour detection influences the predictive capacity of several recognised prognostic and risk factors in patients with breast cancer. Axillary nodal status, tumour progesterone receptor status, and season of tumour detection significantly influenced survival in both older (greater than 50 yrs) and younger (less than 50 yrs) patients. Parity, lactational history, body mass index, tumour oestrogen receptor status, and patient age also influenced survival, but these effects were significant only in age groups less than 50 or greater than 50 yrs. Season of detection of tumour did not effect the prognostic significance of axillary nodal status. However, the effect of oestrogen receptor status on survival was more significant in patients who detected their tumours in the spring/summer compared with winter (odds ratio 0.52 and 0.73 respectively). Negative progesterone receptor status was associated with significant poorer survival only in patients with tumours found in the winter. There was a significant survival disadvantage for nulliparous compared with parous women with breast cancer who were greater than or equal to 50 years at diagnosis, and for women who had never lactated compared with those who had lactated, but this disadvantage was restricted to those who found their tumours in the summer. An increased body mass index (greater than or equal to 28) was associated with decreased survival, but this was significant only for those detecting tumours in winter. The increased incidence of detection of breast cancer in spring/summer may reflect cyclic influences on tumour growth. Such influences may be hormonal in nature and may underlie the effect of season of tumour detection on the prognostic influence of lactation, parity, body mass index, and oestrogen and progesterone receptor status in patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328328     DOI: 10.1007/bf01811887

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  35 in total

1.  Long-term effect of a first pregnancy on the secretion of prolactin.

Authors:  V C Musey; D C Collins; P I Musey; D Martino-Saltzman; J R Preedy
Journal:  N Engl J Med       Date:  1987-01-29       Impact factor: 91.245

2.  Dietary and hormonal interrelationships in premenopausal women: evidence for a relationship between dietary nutrients and plasma prolactin levels.

Authors:  T D Shultz; R B Wilcox; J M Spuehler; B J Howie
Journal:  Am J Clin Nutr       Date:  1987-12       Impact factor: 7.045

3.  Age as a prognostic factor in breast cancer.

Authors:  H Høst; E Lund
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

4.  Clinical trial of 2-Br- -ergocryptine (CB154) in advanced breast cancer.

Authors: 
Journal:  Eur J Cancer       Date:  1972-04       Impact factor: 9.162

Review 5.  Oestrogen receptors and breast cancer: current status.

Authors:  R A Hawkins; M M Roberts; A P Forrest
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

6.  Prognostic significance of prolactin receptors in human breast cancer.

Authors:  J Bonneterre; J P Peyrat; R Beuscart; J Lefebvre; A Demaille
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

7.  The relation between survival and age at diagnosis in breast cancer.

Authors:  H O Adami; B Malker; L Holmberg; I Persson; B Stone
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

8.  Seasonality and breast cancer.

Authors:  N Kirkham; D Machin; D W Cotton; J M Pike
Journal:  Eur J Surg Oncol       Date:  1985-06       Impact factor: 4.424

9.  Endogenous sex hormones, prolactin, and breast cancer in premenopausal women.

Authors:  F Meyer; J B Brown; A S Morrison; B MacMahon
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

10.  Prolactin receptor in human mammary carcinoma.

Authors:  R Di Carlo; G Muccioli
Journal:  Tumori       Date:  1979-12-31
View more
  6 in total

1.  Parity is associated with axillary nodal involvement in operable breast cancer.

Authors:  R K Orr; K M Fraher
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

Review 2.  Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies.

Authors:  D S M Chan; A R Vieira; D Aune; E V Bandera; D C Greenwood; A McTiernan; D Navarro Rosenblatt; I Thune; R Vieira; T Norat
Journal:  Ann Oncol       Date:  2014-04-27       Impact factor: 32.976

Review 3.  Human Chorionic Gonadotropin and Breast Cancer.

Authors:  Susanne Schüler-Toprak; Oliver Treeck; Olaf Ortmann
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

Review 4.  An Exploration of How Solar Radiation Affects the Seasonal Variation of Human Mortality Rates and the Seasonal Variation in Some Other Common Disorders.

Authors:  William B Grant; Barbara J Boucher
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

5.  Seasonal changes in serum melatonin in women with previous breast cancer.

Authors:  I M Holdaway; B H Mason; E E Gibbs; C Rajasoorya; K D Hopkins
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

6.  Parity, age at first childbirth and the prognosis of primary breast cancer.

Authors:  N Kroman; J Wohlfahrt; K W Andersen; H T Mouridsen; T Westergaard; M Melbye
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.